References
Cransac A, Aho S, Boulin M (2019) Comments on: high adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany. Support Care Cancer:1–2. https://doi.org/10.1007/s00520-019-04886-y
Feiten S, Chakupurakal G, Feustel HP, Maasberg M, Otremba B, Ehscheidt P, Hensel M, Hansen R, Weide R (2019) High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany. Support Care Cancer 27:4265–4271. https://doi.org/10.1007/s00520-019-04721-4
Foulon V, Schoffski P, Wolter P (2011) Patient adherence to oral anticancer drugs: an emerging issue in modern oncology. Acta Clin Belg 66(2):85–96. https://doi.org/10.2143/ACB.66.2.2062525
Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS (2006) Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 44(5):471–477. https://doi.org/10.1097/01.mlr.0000207817.32496.cb
Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26(5):331–342
Banning M (2008) Older people and adherence with medication: a review of the literature. Int J Nurs Stud 45(10):1550–1561. https://doi.org/10.1016/j.ijnurstu.2008.02.009
Banning M (2012) Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care (Engl) 21(1):10–19. https://doi.org/10.1111/j.1365-2354.2011.01295.x
Mislang AR, Wildes TM, Kanesvaran R, Baldini C, Holmes HM, Nightingale G, Coolbrandt A, Biganzoli L (2017) Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations. Cancer Treat Rev 57:58–66. https://doi.org/10.1016/j.ctrv.2017.05.002
Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J (2004) How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 13(1):11–19. https://doi.org/10.1002/pds.819
Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497. https://doi.org/10.1056/NEJMra050100
Funding
Our work was supported through a restricted grant from Celgene GmbH, Germany. Celgene had no role in gathering, analyzing, or interpreting the data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Feiten, S., Chakupurakal, G., Feustel, H.P. et al. Response to the letter to the Editor concerning our article “High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany”. Support Care Cancer 28, 3–4 (2020). https://doi.org/10.1007/s00520-019-05126-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-019-05126-z